AxoGen Appoints Karen Zaderej as Chairman of the Board (Biospectrum)

UF startup AxoGen, a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced that its Board of Directors has elected Karen Zaderej as Chairman of the Board in addition to her current role as President and Chief Executive Officer (CEO), effective immediately. Zaderej succeeds Jamie M. Grooms, who will remain a Director of the Board.

In her role as Chairman of the Board, Zaderej will lead efforts in developing and implementing the Company’s strategic vision. AxoGen is creating a platform for nerve repair with innovative solutions and expanding applications to improve the quality of life for patients with peripheral nerve damage.

Learn more about AxoGen Appoints Karen Zaderej as Chairman of the Board.